Background: MicroRNA-27b (miR27b) is a small, non-coding RNA that is involved in
Within the past decade, researchers have focused on the role of microRNAs in different physiological and pathological processes.
These small, non-coding RNA molecules are involved in the control of the cell cycle, and their alterations are associated with inflammatory, autoimmune, and carcinogenic processes. [6] [7] [8] Building on their role in immunity control, several miRNAs (including miR125, miR137, miR147a, miR155, miR181, and miR223) were investigated and found involved in the pathogenesis of OLP and its malignant transformation via alteration of their tissue expression and functions. [9] [10] [11] MicroRNA-27b (miR27b) is a member of the miRNAs family that has been shown involved in the pathogenesis of atherosclerosis, 12, 13 infections, 14, 15 and cancer. 16 Hildebrand and colleagues demonstrated the involvement of miR27b in keratinocyte differentiation, both in vitro and in vivo. 17 Moreover, Zhang and colleagues reported significant downregulation of miR27b expression in OLP patients. 18 Based on these findings, we hypothesized that miR27b could be used as a diagnostic biomarker for OLP. Therefore, we performed this study to investigate this hypothesis, as well as the correlation between miR27b and CD8 (cytotoxic T-cell marker) tissue expression in OLP patients. 
| MATERIALS AND METHODS

| Patients
| Biopsy and histopathological examination
Oral mucosal biopsy was obtained from the non-inflamed gingiva in participating controls and from the lesion mucosa in OLP patients. A part from each specimen was fixed in formalin and paraffin, and then cut using a microtome into 4 μm thick sections. 
| Statistical analysis
To achieve a statistical power of 80% (using MedCalc Software (version The level of statistical significance was assigned at P value ≤ 0.05.
| RESULTS
| Baseline characteristics
The OLP and control groups included 6 (30%) and 13 (65%) males, respectively. The mean age of OLP patients (48.8 ± 8.9 years) was significantly higher than controls (32 ± 10); P < 0.05. The enrolled OLP patients had the following clinical subtypes: atrophic (n = 8), erosive (n = 7), papular (n = 2), plaque (n = 2), and reticular (n = 1). Patients were followed for variable durations from 1 to 48 months (Table 1) .
| CD8 tissue expression
Figures 1,2,3 show the immunohistochemical staining of CD8 T cells in the sub-epithelium of atrophic, erosive, and papular OLP tissues, respectively. We found a statistically significant (P < 0.01) increase in CD8 tissue expression in the OLP group (4.7 ± 2.4), compared to the control group (0.7 ± 0.2). In addition, our analysis revealed a significant difference (P = 0.001) in the same parameter between various OLP subgroups (erosive OLP: 7.2 ± 1.1 > atrophic OLP:
4.1 ± 1.7 > papular/plaque/reticular OLP: 2.1 ± 0.9).
| MicroRNA27b tissue expression
A statistically significant (P < 0.0001) downregulation of miR27b tissue expression was noted in the OLP group (1.6 ± 1.1), compared to AGHBARI ET AL.
| 69 the control group (4.7 ± 1). However, upon comparing different OLP subgroups in this parameter, no statistically significant difference was identified (P = 0.54). The results of tissue expression parameters are illustrated in Table 2 .
Our study data revealed a cutoff value of 4.4 for miR27b tissue expression. To assess the diagnostic accuracy of miR27b as a tissue biomarker for OLP diagnosis, the receiver operating charac- 
| Correlation between miR27b and CD8 tissue levels
The Spearman correlation analysis showed a negative correlation between tissue expression of miR27b and CD8; however, this asso- Pain score measured on a 10-point visual analog scale (the greater score means more perceived pain by the patient).
F I G U R E 1
Immunostaining of CD8 protein (400×) shows the infiltration of CD8 cells in the sub-epithelium of atrophic oral lichen planus tissues. Note the CD8 cells between the basal and suprabasal epithelial cells
| Tissue expression and patients' characteristics
Our analysis showed no significant association between the tissue expression of CD8 or miR27b and the patients' age (Student's t test: P > 0.05), gender, and duration of the disease (Fisher's exact test:
| DISCUSSION
The main finding of the current study is that OLP patients have increased oral mucosal tissue levels of CD8, as well as down-regulated expression of miR27b in comparison with non-OLP controls.
Although not significant, we found a negative correlation between tissue levels of CD8 and miR27b. Further, our study demonstrated that miR27b can be a sensitive biomarker for OLP diagnosis. These findings fit within the reported data in the literature of altered | 71 miRNAs expression in OLP and the ability of such alterations to serve as diagnostic biomarkers for OLP.
The increased lesional tissue expression of CD8 in our study confirms the role of T cells in OLP pathogenesis. 19, 20 Previous investigators reported T-cytotoxic cells as the predominant T-cell type in OLP lesions, 21 whereas others reported the same for T-helper cells. 22 These immunophenotypic differences may be related to disease stage that is, the increased T-helper cell infiltration in early disease prompts the T-cytotoxic cell influx at late stages. 19 Moreover, the T-helper/T-cytotoxic cell ratio has been found to vary in different OLP subtypes with increased ratio with the plaque form and decreased ratio with the atrophic form. 23 Our immunostaining findings confirm these results, as well as those of Vered et al 24 who
reported variable CD8 tissue levels in different OLP clinical subtypes.
Further, we found a significant downregulation of miR27b tissue expression in OLP patients, compared to normal tissues, which is in agreement with the results by Zhang et al. 18 However, in compar- Further, recent data have shown correlations between miRNAs levels and lesional T-cell infiltration and activity. Our previous work showed a negative correlation between miR137 and CD8 tissue expression in OLP patients. 9 Moreover, Zheng and Li showed that miR214 suppresses CD44 expression, which prevents the apoptosis of activated CD8 T cells. 28 Another study by Hu et al 29 showed that elevated miR155 increases the proliferation of CD4 T cells. Collectively, the alteration in miRNAs levels may play a role in OLP pathogenesis by increasing mucosal T-cell infiltration and the release of pro-inflammatory cytokines.
In addition, we found a high sensitivity for tissue miR27b expression as a biomarker for OLP with a sensitivity as high as 100%. The as a surrogate biomarker for OLP activity, alone or in combination with other miRNAs. 30 Of note, our study failed to document a significant association between miR27b expression and patients' characteristics as age, gender, and disease duration, which may be due to our relatively small sample size and should be further investigated in future studies. Moreover, the potential of miR27b overexpression as a therapeutic strategy to reduce immune activity in OLP lesions should be considered.
In conclusion, our study demonstrated increased CD8 levels and downregulation of miR27b in OLP tissues, compared to healthy tissues. Therefore, miR27b expression may be a possible candidate for drug development. Moreover, it reveals the potential of miR27b as OLP disease biomarker. The possible negative correlation between CD8 and miR27b tissue expression requires further confirmation in larger studies.
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